newsfilter
← Latest News
GlobeNewswire·

Statera Biopharma Advances Next-Gen Proprietary Compositions Based on STAT-200 Platform

In collaboration with MolSoft, ImQuest, a Statera company, is investigating new, optimized compositions incorporating desirable elements of STAT-200 FORT COLLINS, Colo., March 07, 2022 (GLOBE NEWSWIRE) -- Statera Biopharma, Inc. (NASDAQ:STAB), a lea